GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members
2023年10月12日 - 10:00PM
ビジネスワイヤ(英語)
Eligible Navitus members can now automatically
access real-time comparative pricing at point of sale to improve
affordability
GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings
and information, and Navitus Health Solutions, LLC, a pass-through
pharmacy benefit manager (PBM) committed to removing cost from the
drug supply chain, today announced the launch of Savings Connect.
This program, when elected by clients, provides members with
automatic access to GoodRx prices on generic drugs in a seamless
experience at the pharmacy counter. Consumers no longer have to
proactively review and choose between using their insurance or a
discounted price available through GoodRx. Both prices are compared
behind the scenes and the lowest one is delivered directly to the
consumer.
“We are focused on expanding into the insurance benefit market
because we see the value that transparency and significant savings
provide to all relevant stakeholders,” said Cynthia Meiners,
Strategic Program Development Officer at GoodRx. “We are excited to
partner with Navitus to deliver lower-cost prescriptions to their
members, and also strengthen the impact of our prescription savings
within the insurance benefit marketplace.”
No additional action is required by eligible Navitus members to
access GoodRx savings through the Savings Connect program.
Individuals simply show their existing Navitus benefit card at the
pharmacy counter, and then GoodRx and Navitus automatically review
and identify the best prescription cost available. The amount paid
by the member is applied to the deductible and out of pocket
maximum. This process also leverages clinical data integration to
ensure all claims remain associated with the member’s prescription
record.
“Navitus strives to make medications more affordable for the
people who need them. As healthcare costs rise, it is critical that
we align with companies that share our mission to drive out
needless costs for our members,” said David Fields, CEO of Navitus
Health Solutions. “We are thrilled to be collaborating with GoodRx
to deliver lower prices for our members while creating a seamless
experience at the pharmacy.”
Eligible Navitus members can already take advantage of the
Savings Connect program on many commonly prescribed generic
prescriptions at in-network pharmacies, with an accelerated rollout
to additional clients expected in January 2024. This program was
previously introduced to clients of EpiphanyRx, Navitus’ in-house
solution for emerging and mid-market employer groups, in Q4
2022.
About GoodRx
GoodRx is a leading resource for healthcare savings and
information that makes healthcare affordable and convenient for all
Americans. We offer consumers free access to transparent and lower
prices for brand and generic medications, affordable and convenient
medical provider consultations via telehealth, and comprehensive
healthcare research and information. Since 2011, we have helped
consumers save over $60 billion and are one of the most downloaded
medical apps over the past decade.
GoodRx periodically posts information that may be important to
investors on its investor relations website at
https://investors.goodrx.com. We intend to use our website as a
means of disclosing material nonpublic information and for
complying with our disclosure obligations under Regulation FD.
Accordingly, investors and potential investors are encouraged to
consult GoodRx’s website regularly for important information, in
addition to following GoodRx’s press releases, filings with the
Securities and Exchange Commission (the “SEC”) and public
conference calls and webcasts. The information contained on, or
that may be accessed through, GoodRx’s website is not incorporated
by reference into, and is not a part of, this press release.
About Navitus
Navitus Health Solutions, LLC, owned by SSM Health and Costco
Wholesale Corporation, was founded in 2003 as an alternative to
traditional pharmacy benefit management (PBM) models. Navitus
approaches pharmacy services differently. We are purpose-driven to
help humans and committed to removing cost from the drug supply
chain to make medications more affordable for the people who need
them. We proudly serve over 11 million people through more than
1,000 plan sponsor and health plan client relationships. Our
transparent, fully pass-through model enables clients to achieve
their goals and drive desired health and financial outcomes. To
learn more about Navitus, visit navitus.com.
GoodRx Forward-looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements contained in this press release that do not
relate to matters of historical fact should be considered
forward-looking statements, including, without limitation,
statements regarding consumer savings; the demand and success of
the Savings Connect program and the benefits to consumers and
GoodRx from such offering; and GoodRx’s plans, expectations and
objectives regarding the Savings Connect program and the insurance
benefit market. These statements are neither promises nor
guarantees, but involve known and unknown risks, uncertainties and
other important factors that may cause actual results, performance
or achievements to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements, including, but not limited to, risks
relating to changes in medication pricing which are significantly
impacted by pricing structures negotiated by industry participants;
GoodRx’s ability to achieve broad market education and change
consumer purchasing habits; GoodRx’s reliance on a limited number
of industry participants; risks related to government regulation of
the internet, e-commerce, consumer data and privacy, information
technology and cyber-security; and the important factors discussed
in the sections entitled “Risk Factors” in GoodRx’s Annual Report
on Form 10-K for the year ended December 31, 2022, as updated by
GoodRx’s Quarterly Report on Form 10-Q for the quarter ended June
30, 2023, and GoodRx’s other filings with the SEC. These factors
could cause actual results to differ materially from those
indicated by the forward-looking statements made in this press
release. Any such forward-looking statements represent current
expectations and projections as of the date of this press release.
While we may elect to update such forward-looking statements at
some point in the future, we disclaim any obligation to do so, even
if subsequent events cause our views to change.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231012225774/en/
Media GoodRx press@goodrx.com
Navitus Navitus@AllisonWorldwide.com
GoodRx (NASDAQ:GDRX)
過去 株価チャート
から 4 2024 まで 5 2024
GoodRx (NASDAQ:GDRX)
過去 株価チャート
から 5 2023 まで 5 2024